BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

421 related articles for article (PubMed ID: 21544705)

  • 21. Prevalence and Correlates of Persistent HIV-1 RNA in Cerebrospinal Fluid During Antiretroviral Therapy.
    Anderson AM; Muñoz-Moreno JA; McClernon DR; Ellis RJ; Cookson D; Clifford DB; Collier AC; Gelman BB; Marra CM; McArthur JC; McCutchan JA; Morgello S; Sacktor N; Simpson DM; Franklin DR; Heaton RK; Grant I; Letendre SL;
    J Infect Dis; 2017 Jan; 215(1):105-113. PubMed ID: 27789723
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cerebral white matter integrity during primary HIV infection.
    Wright PW; Vaida FF; Fernández-de Thomas RJ; Rutlin J; Price RW; Lee E; Peterson J; Fuchs D; Shimony JS; Robertson KR; Walter R; Meyerhoff DJ; Spudich S; Ances BM
    AIDS; 2015 Feb; 29(4):433-42. PubMed ID: 25513818
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Symptomatic cerebrospinal fluid escape.
    Mastrangelo A; Turrini F; de Zan V; Caccia R; Gerevini S; Cinque P
    AIDS; 2019 Dec; 33 Suppl 2():S159-S169. PubMed ID: 31789816
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cerebrospinal fluid extracellular vesicles and neurofilament light protein as biomarkers of central nervous system injury in HIV-infected patients on antiretroviral therapy.
    Guha D; Mukerji SS; Chettimada S; Misra V; Lorenz DR; Morgello S; Gabuzda D
    AIDS; 2019 Mar; 33(4):615-625. PubMed ID: 30557159
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Delayed central nervous system virus suppression during highly active antiretroviral therapy is associated with HIV encephalopathy, but not with viral drug resistance or poor central nervous system drug penetration.
    Eggers C; Hertogs K; Stürenburg HJ; van Lunzen J; Stellbrink HJ
    AIDS; 2003 Sep; 17(13):1897-906. PubMed ID: 12960822
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of CD4+ blood cell count and HIV viral load on treatment response with direct acting antivirals in HIV and HCV coinfected patients: insights from the German Hepatitis C-Registry.
    Bischoff J; Mauss S; Cordes C; Lutz T; Scholten S; Cornberg M; Manns MP; Baumgarten A; Rockstroh JK
    HIV Clin Trials; 2018 Dec; 19(6):225-234. PubMed ID: 30890063
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reversible dementia in a patient with central nervous system escape of human immunodeficiency virus.
    Bogoch II; Davis BT; Venna N
    J Infect; 2011 Sep; 63(3):236-9. PubMed ID: 21658774
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Associations of gender and serum total cholesterol with CD4+ T cell count and HIV RNA load in antiretroviral-naïve individuals in Addis Ababa.
    Adal M; Howe R; Kassa D; Aseffa A; Petros B
    BMC Public Health; 2018 Jul; 18(1):943. PubMed ID: 30064395
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antiretroviral treatment alters relationship between MCP-1 and neurometabolites in HIV patients.
    Chang L; Ernst T; St Hillaire C; Conant K
    Antivir Ther; 2004 Jun; 9(3):431-40. PubMed ID: 15259906
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of hepatitis C virus (HCV) viremia and HCV genotype in the immune recovery from highly active antiretroviral therapy in a cohort of antiretroviral-naive HIV-infected individuals.
    Antonucci G; Girardi E; Cozzi-Lepri A; Capobianchi MR; De Luca A; Puoti M; Petrelli E; Carnevale G; Rizzardini G; Grossi PA; Viganò P; Moioli MC; Carletti F; Solmone M; Ippolito G; Monforte AD; ;
    Clin Infect Dis; 2005 Jun; 40(12):e101-9. PubMed ID: 15909251
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantifying HIV-1 RNA using the polymerase chain reaction on cerebrospinal fluid and serum of seropositive individuals with and without neurologic abnormalities.
    Conrad AJ; Schmid P; Syndulko K; Singer EJ; Nagra RM; Russell JJ; Tourtellotte WW
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Dec; 10(4):425-35. PubMed ID: 7583438
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cerebrospinal fluid (CSF) biomarkers of iron status are associated with CSF viral load, antiretroviral therapy, and demographic factors in HIV-infected adults.
    Patton SM; Wang Q; Hulgan T; Connor JR; Jia P; Zhao Z; Letendre SL; Ellis RJ; Bush WS; Samuels DC; Franklin DR; Kaur H; Iudicello J; Grant I; Kallianpur AR
    Fluids Barriers CNS; 2017 Apr; 14(1):11. PubMed ID: 28427421
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cerebrospinal fluid cell-free mitochondrial DNA is associated with HIV replication, iron transport, and mild HIV-associated neurocognitive impairment.
    Mehta SR; Pérez-Santiago J; Hulgan T; Day TR; Barnholtz-Sloan J; Gittleman H; Letendre S; Ellis R; Heaton R; Patton S; Suben JD; Franklin D; Rosario D; Clifford DB; Collier AC; Marra CM; Gelman BB; McArthur J; McCutchan A; Morgello S; Simpson D; Connor J; Grant I; Kallianpur A
    J Neuroinflammation; 2017 Mar; 14(1):72. PubMed ID: 28359324
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Compartmentalization of cerebrospinal fluid inflammation across the spectrum of untreated HIV-1 infection, central nervous system injury and viral suppression.
    Gisslen M; Keating SM; Spudich S; Arechiga V; Stephenson S; Zetterberg H; Di Germanio C; Blennow K; Fuchs D; Hagberg L; Norris PJ; Peterson J; Shacklett BL; Yiannoutsos CT; Price RW
    PLoS One; 2021; 16(5):e0250987. PubMed ID: 33983973
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical and virological correlation between the cerebrospinal fluid and blood of HIV-infected children].
    Sáez-Llorens X; Castrejón de Wong MC; Castaño E; de Suman O; Báez de Ulloa C; Redondo W; Espino M
    Rev Med Panama; 2001; 26():13-8. PubMed ID: 16161718
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Apolipoprotein E ε4 genotype status is not associated with neuroimaging outcomes in a large cohort of HIV+ individuals.
    Cooley SA; Paul RH; Fennema-Notestine C; Morgan EE; Vaida F; Deng Q; Chen JA; Letendre S; Ellis R; Clifford DB; Marra CM; Collier AC; Gelman BB; McArthur JC; McCutchan JA; Simpson DM; Morgello S; Grant I; Ances BM;
    J Neurovirol; 2016 Oct; 22(5):607-614. PubMed ID: 27021072
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatitis C infection on immune recovery in HIV-positive patients on successful HAART: the role of genotype 3.
    Seminari E; Tinelli C; Ravasi G; Ripamonti D; Ladisa N; Marino N; Sighinolfi L; Mondello P; Migliorino M; Carosi G; Maserati R;
    Curr HIV Res; 2010 Apr; 8(3):186-93. PubMed ID: 20163342
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasma and Cerebrospinal Fluid Biomarkers Predict Cerebral Injury in HIV-Infected Individuals on Stable Combination Antiretroviral Therapy.
    Anderson AM; Harezlak J; Bharti A; Mi D; Taylor MJ; Daar ES; Schifitto G; Zhong J; Alger JR; Brown MS; Singer EJ; Campbell TB; McMahon DD; Buchthal S; Cohen R; Yiannoutsos C; Letendre SL; Navia BA;
    J Acquir Immune Defic Syndr; 2015 May; 69(1):29-35. PubMed ID: 25622053
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationship between human immunodeficiency virus-associated dementia and viral load in cerebrospinal fluid and brain.
    McArthur JC; McClernon DR; Cronin MF; Nance-Sproson TE; Saah AJ; St Clair M; Lanier ER
    Ann Neurol; 1997 Nov; 42(5):689-98. PubMed ID: 9392567
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cerebrospinal fluid mononuclear cell counts influence CSF HIV-1 RNA levels.
    Martin C; Albert J; Hansson P; Pehrsson P; Link H; Sönnerborg A
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Mar; 17(3):214-9. PubMed ID: 9495220
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.